Revance Therapeutics Inc (RVNC)

[usma67korea]

1) investors and market concern for debt convertibles.

2) cannot do any more offerings.

3) cannot miss revenue estimates

4) accelerate lowering expenses further. still way too heavy on expenses for sub $500M company

no one believes Foley. not analysts. not investors. surely not shorts. this is not a one time event to turnaround, but he needs to earn trust. communicate progress more often. lessen debt/financing concerns we all have